J&J to seek FDA authorization for booster shot; GlaxoSmithKline to send 10,000 doses of COVID-19 treatment to Canada; Researchers find targeted brain stimulation may treat depression.
London-based drugmaker GlaxoSmithKline PLC said on Monday it signed a deal to supply 10,000 doses of its COVID-19 monoclonal antibody therapy to the Canadian government.